Case number 1:23-cv-00556
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 14, 2023 | 16 | MOTION for Pro Hac Vice Appearance of Attorney T.O. Kong, Wendy L. Devine, Elham Firouzi Steiner and Ty W. Callahan of Wilson Sonsini Goodrich & Rosati P.C. - filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 06/14/2023) (6) |
| Jun 6, 2023 | 13 | STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/7/2023 (nms). (Entered: 06/06/2023) (2) |
| Jun 6, 2023 | 14 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH; Corporate Parent no parent corporation for Bayer AG filed by Bayer AG, Bayer Intellectual Property GMBH. (Fahnestock, Derek) (Entered: 06/06/2023) (2) |
| Jun 6, 2023 | 15 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 06/06/2023) (2) |
| Jun 2, 2023 | 10 | WAIVER OF SERVICE returned executed by Mylan Pharmaceuticals Inc.: For Janssen Pharmaceuticals, Inc. waiver sent on 5/23/2023, answer due 7/24/2023. (Moore, David) (Entered: 06/02/2023) (1) |
| Jun 2, 2023 | 11 | WAIVER OF SERVICE returned executed by Mylan Pharmaceuticals Inc.: For Bayer Intellectual Property GMBH waiver sent on 5/23/2023, answer due 8/21/2023. (Moore, David) (Entered: 06/02/2023) (1) |
| Jun 2, 2023 | 12 | WAIVER OF SERVICE returned executed by Mylan Pharmaceuticals Inc.: For Bayer AG waiver sent on 5/23/2023, answer due 8/21/2023. (Moore, David) (Entered: 06/02/2023) (1) |
| May 25, 2023 | 9 | Letter to Clerk of Court, from David E. Moore, regarding the remark entered on the docket regarding MDL affiliation. (Moore, David) Modified on 5/25/2023 (nms). (Entered: 05/25/2023) (1) |
| May 22, 2023 | 7 | ORAL ORDER: The Motion for Leave to File Complaint and Exhibit B Under Seal (D.I. 1 ) is GRANTED in part and DENIED in part. The request to seal the complaint is DENIED and the request to file Exhibit B under seal is GRANTED. Ordered by Judge Richard G. Andrews on 5/22/2023. (nms) (Entered: 05/22/2023) (0) |
| May 22, 2023 | 8 | [SEALED] EXHIBIT B to 2 Complaint, by Mylan Pharmaceuticals Inc.. (nms) (Entered: 05/22/2023) (0) |
| May 19, 2023 | 2 | Complaint* (1) |
| May 19, 2023 | 3 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jdb) (Entered: 05/22/2023) (3) |
| May 19, 2023 | 4 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/14/2018. Date of Expiration of Patent: 11/13/2024. (jdb) (Entered: 05/22/2023) (1) |
| May 19, 2023 | 5 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,415,053 B2. (jdb) (Entered: 05/22/2023) (1) |
| May 19, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent's Mylan Inc. and Viatris Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc. (jdb) (Entered: 05/22/2023) (2) |
